Researchers at Mount Sinai are sending bioengineered human brain and cardiovascular tissue models into space to study the effects of microgravity and radiation on human health. The investigations are traveling to the International Space Station as part of the SpaceX CRS-35 mission, according to a Mount Sinai announcement published October 13.
The experiments use organoids and organ-chip systems, miniature biological models designed to reproduce selected features of human tissues. The brain models are derived from induced pluripotent stem cells, while the cardiovascular systems are intended to help researchers examine changes in heart-related function. The mission will expose the models to conditions that are difficult to reproduce fully on Earth.
Spaceflight creates a combination of stresses that may accelerate or reveal biological processes. Microgravity changes how cells organize and communicate, while radiation can damage DNA and affect tissue function. Studying these effects may help researchers understand risks faced by astronauts during long missions, including future journeys to the Moon or Mars.
The work may also have relevance for medicine on Earth. If space conditions reveal mechanisms associated with aging, neurodegeneration or cardiovascular decline, researchers could use the models to test drugs and interventions more efficiently. The value of organoids and organ chips lies partly in their ability to provide human-derived experimental systems without relying exclusively on animal models.
The experiments are not intended to reproduce the whole human body. Tissue models lack many features of an intact organism, including complete immune, hormonal and circulatory interactions. Results must therefore be interpreted carefully and compared with laboratory studies, animal research and clinical data.
Even with those limitations, the research represents an important step in the development of space-based biomedical science. The International Space Station functions as a laboratory where investigators can study biological processes under unusual physical conditions. Commercial cargo and launch services have made it more practical to send increasingly sophisticated experiments into orbit, expanding opportunities for universities and health systems.
The institutional importance is twofold. NASA and other space agencies need better evidence on how to protect crews during longer missions. At the same time, pharmaceutical and biotechnology researchers are exploring whether microgravity can expose disease mechanisms or improve the manufacture of biological products.
The first data will not immediately translate into new treatments. Researchers must determine whether changes observed in orbit are reproducible, whether they persist after return to Earth and whether they correspond to clinically relevant disease pathways. Still, the mission demonstrates how space research is increasingly connected to mainstream biomedical science, with human tissue engineering serving as a bridge between astronaut health and terrestrial medicine.
Sources: - https://www.mountsinai.org/about/newsroom/2026/mount-sinai-scientists-to-send-human-tissue-models-into-space-to-study-brain-heart-health-and-aging-in-microgravity - https://www.nasa.gov/international-space-station/